-+ 0.00%
-+ 0.00%
-+ 0.00%

SILEXION THERAPEUTICS: TO SUBMIT PHASE 2/3 CLINICAL TRIAL APPLICATION IN GERMANY BY QTR-END, EXTRA REGULATORY FILINGS ACROSS EU IN EARLY 2027

Reuters·03/24/2026 12:37:23

Please log in to view news